UCA1 upregulates glutamate pyruvate transaminase 2 (GPT2) expression through interaction with heterogeneous nuclear ribonucleoprotein I/L, and promotes glutamine driven bladder cancer reperfusion 22. The gene discussed is GPT2; the disease is urinary bladder carcinoma.